Full-Time

Territory Sales Executive

LA North

Posted on 8/6/2024

Tempus

Tempus

1,001-5,000 employees

AI-driven healthcare data analysis platform

Compensation Overview

$90k - $150k/yr

+ Incentive Compensation

Mid

Company Historically Provides H1B Sponsorship

Los Angeles, CA, USA

Role is based in Los Angeles, CA.

Category
Strategic Account Management
Sales & Account Management
Required Skills
Sales
Communications
Salesforce
Marketing
Customer Service
PowerPoint/Keynote/Slides
Requirements
  • Ability to provide an integrated MolDx/SaaS solution using Tempus’s sequencing technology to prospects and customers.
  • Ability to engage in a consultative selling process that overcomes objections and indifferences while connecting client needs with Tempus’ capabilities.
  • Comfortable selling at the executive level (CEO, COO, CFO)
  • Keen understanding of the payor and reimbursement environment in the oncology and diagnostic space
  • Ability to work independently, communicate proactively, manage multiple projects and prioritize daily tasks while managing critical deadlines
  • Strong understanding of molecular diagnostics for oncology and the evolving competitive landscape
  • Ability to maintain an outstanding level of market, customer, distribution and product knowledge necessary to accomplish sales and marketing objectives
  • Excellent knowledge of oncology, hematology, chemotherapeutics and targeted agents
  • Excellent negotiation and customer service skills
  • Outstanding strategic sales account planning skills
  • Superior listening and problem solving skills
  • Ability to handle sensitive information and maintain a very high level of confidentiality
  • Demonstrate consistent closing abilities throughout the sales cycle
  • Possess a very positive attitude and an understanding of the dynamics involved with organizational growth and change
  • Impeccable oral and verbal communication and presentation skills
  • Must be very proficient with all Microsoft Office products – particularly Excel and PowerPoint
  • Effective and regular utilization of Salesforce.com
  • Ability to develop and utilize cross-functional relationships to facilitate the accomplishment of work goals and objectives.
  • Advanced presentation skills and business acumen a necessity
  • Ability to work effectively with minimal direction from, or interface with, manager
  • Problem solving, decision making and technical learning
  • Advanced written and oral communication skills
  • Strong administrative skills and sophistication to manage business in complex environments
  • Demonstrate Tempus’ Values by acting with integrity, respect and trust
  • Frequent travel ( > 50%) throughout the territory as needed
  • B.S. in life science, biology, business or marketing – MBA preferred
  • 2-3 years of direct account management experience in a molecular diagnostic setting with a history of proven past performance that has met and exceeded expectations.
  • Candidate must have 3-5 years of experience working with major cancer centers and clinics, oncology GPO’s, large health systems, IHDN’s, and large oncology practices.
  • Demonstrated measurable revenue generation at either a diagnostic, pharmaceutical or relevant biotechnology company.
Responsibilities
  • Drive strategic business expansion/collaboration opportunities with the following: Major U.S. cancer centers and clinics / Top 20 largest oncology practices in the territory; Key Opinion Leaders (KOLs) and Academic Medical Centers (AMCs) within the specified territory.
  • Structure detailed strategic plans for gaining and retaining new and existing clients.
  • Maximize client-bill contracting opportunities
  • Implement laboratory services agreements (LSA’s) with bill account institutions
  • Collaborate and coordinate with all sales positions (VP, Sales, RSD’s, DSM’s, SAM’s, and GL’s) to ensure successful attainment of company goals and objectives
  • Identify and develop partnering opportunities between prospective oncology clients and Tempus.
  • Promote and drive compliance with new web-based molecular information tools for all clients
  • Continually analyze competitive landscape and environment within assigned accounts to determine trends and provide customer feedback to Tempus leadership
  • Monitor performance of sales to ensure objectives are met
  • Develop and implement a comprehensive business plan for the territory that will be inclusive of budgets, travel, territory management, goal setting, etc.
  • Work effectively with individuals across multiple departments throughout Tempus
  • Embrace, embody and represent the Tempus company culture at all times to external and internal constituents.

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, distinguishing itself through its focus on personalized medicine and extensive cancer research.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Chicago, Illinois

Founded

2015

Simplify Jobs

Simplify's Take

What believers are saying

  • Acquisition of Deep 6 AI expands Tempus' data network and precision medicine capabilities.
  • $560 million debt financing supports Tempus' growth and AI-driven healthcare solutions.
  • Collaboration with Artera enhances AI cancer test access, increasing Tempus' oncology influence.

What critics are saying

  • Integration challenges with Deep 6 AI could delay Tempus' expansion plans.
  • $560 million debt financing increases financial leverage, posing risk if revenue growth lags.
  • Exclusive partnership with Artera may limit Tempus' collaboration opportunities in prostate testing.

What makes Tempus unique

  • Tempus uses AI to analyze clinical and molecular data for precision medicine.
  • Their platform aids drug development by discovering novel targets and evaluating treatments.
  • Tempus' pan-cancer organoid platform enhances personalized therapeutic opportunities for cancer patients.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Relocation Assistance

Company Equity

Performance Bonus

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Life Care News
Mar 30th, 2025
Tempus Exhibits 4 Abstracts at the 2025 American College of Cardiology Annual Meeting

Tempus exhibits 4 abstracts at the 2025 American College of Cardiology Annual Meeting.

Tempus
Mar 12th, 2025
Tempus Announces Acquisition of Deep 6 AI | Tempus AI

Deep 6 is integrated with over 750 provider site locations spanning more than 30 million patients, which will materially add to Tempus’ existing network CHICAGO --(BUSINESS WIRE)--Mar. 11, 2025-- Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision

TipRanks
Mar 12th, 2025
Tempus AI (TEM) Strengthens Precision Medicine with Deep 6 AI Deal, Cathie Wood Buys the Dip

Tempus AI has acquired Deep 6 AI to expand its reach and enhance offerings in precision medicine.

Business Wire
Feb 25th, 2025
Ares Management Upsizes Tempus Debt Facilities to $560 Million

Combined with $260 million of capital provided in 2022 and 2023, Ares Credit funds have provided Tempus a total debt package of approximately $560 million.

Pulse 2.0
Feb 24th, 2025
Tempus Secures $560M Debt Financing

Ares Management announced that Ares Credit funds provided $300 million in additional debt financing to Tempus AI, bringing the total debt package to $560 million. This financing supports Tempus' acquisition of Ambry Genetics, completed on February 3, 2025. Ares praised Tempus' growth strategy and AI-enabled solutions in medicine. Tempus' CFO, Jim Rogers, expressed appreciation for Ares' investment, which aids in enhancing healthcare technology and patient outcomes.

INACTIVE